Gihan Tennekoon
Neurology · Philadelphia, PANPI 1740297779
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (40.7%), education and speaking fees — rather than concentrated in one kind of arrangement. 3 manufacturers reported payments, led by Novartis Gene Therapies, Inc. (fka Avexis, Inc.) at 43.6% of the total. Reporting peaked in 2019 at $15,580 and has fallen 99.2% since, to $118 in 2023.
Across 43 payments — averaging $449.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$8K
- Genentech, Inc.$6K
- Sarepta Therapeutics, Inc.$5K
Across 51 payments — averaging $6958.87 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$176K
- PTC Therapeutics, Inc.$95K
- Sarepta Therapeutics, Inc.$57K
- Hoffmann-la Roche Limited$24K
- Novartis$2K
What the payments were for
- Consulting fees$7,88041%
- Speaking & faculty fees$2,25712%
- Travel & lodging$2,22612%
- Food & beverage$7934%
- Education$6,19032%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | 25 | $8,438 |
| Genentech, Inc. | 7 | $6,351 |
| Sarepta Therapeutics, Inc. | 11 | $4,557 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZOLGENSMA$8,438
- Non-Covered Product$6,312
- Exondys 51$4,377
How this compares
$19,346 in reported general payments places this provider in the 80th percentile of 941 neurology providers in Pennsylvania.
Other neurology in Philadelphia
- Daniel KremensPhiladelphia$1.8M
- Thomas LeistPhiladelphia$1.4M
- Jill Giordano FarmerPhiladelphia$1.2M
- Stephanie Nahas-GeigerPhiladelphia$786K
- Amit Bar-OrPhiladelphia$596K
- Stephen SilbersteinPhiladelphia$428K
- Joseph BergerPhiladelphia$384K
- Sami KhellaPhiladelphia$285K
- Clyde MarkowitzPhiladelphia$274K
- Matthew SternPhiladelphia$251K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.